safe and effective
The FDA announced on Thursday it is limiting the use of the Janssen COVID-19 vaccine to people 18 or older after an investigation found that those who received the jab were at risk of blood clots.
www.dailymail.co.uk
FDA LIMITS use of Johnson & Johnson COVID vaccine due to risk of life-threatening blood clots - a year after it lifted pause on one-shot regimen taken by 18 million
- The FDA is limiting the use of the Johnson and Johnson COVID-19 vaccine
- It is now only authorizing the jab to people 18 or older for whom other COVID vaccines aren't available or aren't appropriate
- Those 18 and older who otherwise would not get a COVID vaccine are also authorized to use the Johnson and Johnson jab
- The decision comes after an investigation revealed those who got the vaccine were at increased risk for thrombosis and thrombocytopenia syndrome
- The syndrome creates blood clots and decreases blood platelet levels
- Symptoms started in those cases just one to two weeks after receiving the jab
By
MELISSA KOENIG FOR DAILYMAIL.COM
PUBLISHED: 17:42 EDT, 5 May 2022 | UPDATED: 20:57 EDT, 5 May 2022
BREAKING: FDA limits use of Janssen COVID-19 vaccine
The Food and Drug Administration announced Thursday it will restrict the use of the
Johnson & Johnson one-shot
COVID-19 vaccine after an investigation revealed that those who got the jab were at increased risk of developing life-threatening blood clots.
The agency is now only authorizing the pharmaceutical giant's Janssen COVID vaccine to people 18 or older for whom other authorized or approved vaccines are not accessible or clinically appropriate, and to those 18 years or older who otherwise would not get a COVID vaccine.
The decision comes following an investigation into reports of thrombosis and thrombocytopenia syndrome (TTS) - a rare and potentially life-threatening disease that creates blood clots and creates low levels of blood platelets - from those who have received the vaccine.